Leadership Group:
Mirella Marlow, MBA, MA, Programme Director, Devices and Diagnostic Systems, Centre for Health Technology Evaluation, The National Institute for Health and Care Excellence (NICE), London, England, United Kingdom
Karolina Socha-Dietrich, Organization for Economic Cooperation and Development (OECD), Copenhagen, Denmark
Adriana Velazquez Berumen, MSc, Senior Advisor and Focal Point on Medical Devices, World Health Organization (WHO), Geneva, Switzerland
Yves Verboven, Director, Market Access & Economic Policies MedTech Europe, Brussels, Belgium
Øyvind Melien, MD, PhD, MSc, Specialist in Clinical Pharmacology and Chair of Secretariat for the Norwegian National System for Managed Introduction of Health Technologies within the Specialist Health Services. Dept. of Medical Devices and Medicinal Products Norwegian Directorate of Health, Oslo, Norway
Claudia Wild, PhD, Director, Ludwig Boltzman Institute for Health Technology Assessment (LBI-HTA), and EUnetHTA, Austria
Reinhard Busse, MPH, University of Berlin, MEDTecHTA, Germany
Giuditta Callea, PhD, University of Bocconi, MedTecHTA, Italy
Jing Xie, PhD, Vice President, Clinical Affairs, Medical Device Innovation Consortium (MDIC), USA
Ralph Ives, Executive Vice President of Global Strategy and Analysis, AdvaMed, USA
Edward L. Trimble, MD, MPH, Director, Center for Global Health, National Cancer Institute, National Institute of Health, USA
Paul C. Pearlman, PhD, Science Policy Advisor/Program Officer, Center for Global Health, National Institutes of Health, National Cancer Institute, USA
TBD, Representatives from Asia-Pacific and Latin America
Objective:
Provide global harmonization and consistency in utilizing and adapting health technology assessment as a supportive tool to inform decisions in the lifecycle of medical technologies to the benefit of the patients, health systems, and society including the value of other tools and initiatives on novel value frameworks to inform decisions and meet the policy objectives.